摘要
目的探讨胺碘酮治疗心律失常的临床疗效和安全性。方法对我院已确诊的96例心律失常患者均在常规的强心、扩血管、利尿、心肌细胞营养剂等治疗及心电监护下,静脉及口服应用胺碘酮治疗。结果显效70例,占72.9%,有效16例,占16.7%,无效10例,占10.4%,总有效率为89.6%。其中不良反应出现了低血压3例,恶心呕吐5例,降低胺碘酮的滴注速度症状均可缓解或消失。结论胺碘酮抗心律失常疗效好,不良反应少,安全性高,可作为一线抗心律失常药物进行临床推广。
Objective To observe and analyze the clinical efficacy and safety of amiodarone treated for cardiac arrhythmia.Methods 96 patients with cardiac arrhythmia diagnosed in our hospital were given the conventional treatment of stong heart,vascular dilatation,diuresis and myocardial cell nutrition agent and received the treatment of intravenous and oral administration of amiodarone under the monitor of ECG.Results There were 70 evidently effective cases which accounted for 72.9%,16 effective cases accounting for 16.7% and 10 invalid cases accounting for 10.4%.The total efficiency was 89.6%.As for the adverse reactions,there were 3 patients appearing hypotension and 5 patients with nausea and vomiting.Reducing the infusion speed of amiodarone could make the symptoms relieved or disappeared.Conclusion Amiodarone treating cardiac arrhythmia has good clinical effect and less adverse reactions,which can be regarded as the first-line antiarrhythmic medicine to be promoted and applied.
出处
《中国现代医药杂志》
2012年第11期59-60,共2页
Modern Medicine Journal of China
关键词
心律失常
胺碘酮
临床疗效
Cardiac arrhythmia Amiodarone Clinical efficacy
